中文版 | English

个人主页

关键词云

成果统计

合作作者[TOP 5]

  • 王皞鹏

    合作成果数：9

  • 邱士真

    合作成果数：8

  • 王琨

    合作成果数：3

  • 范高峰

    合作成果数：2

  • 李丽

    合作成果数：2
李文涛 博士生
所在学院： 生命科学与技术学院
职务： --
研究方向：
备注： --
李文涛

科研成果

10 4143 309 189 0 2
Items Views Downloads TC[WOS] TC[CSCD] H-index
排序方式：
 [1] Yao, Bin,Ye, Xueting,Kong, Qian,et al. Phosphotyrosine Signal Profiling of Clinical CAR-T Reveals Tonic Signaling Associated with Therapeutic Efficacy. 2024.浏览/下载:75/0; 被引[WOS]:0评论推荐收藏
 [2] 王皞鹏,邱士真,李文涛,等. 一种泛素偶联修饰的嵌合抗原受体及免疫细胞. 2023-02-03.浏览/下载:528/0评论推荐收藏
 [3] Wang Haopeng,Qiu Shizhen,Li Wentao,et al. Chimeric Antigen Receptor Modified By Ubiquitin Coupling And Immune Cell. 2023-02-02.浏览/下载:416/0评论推荐收藏
 [4] Chen, Jian.,Qiu, Shizhen.,Li, Wentao.,Wang, Kun.,Zhang, Yu.,...&Wang, Haopeng.(2023).Tuning charge density of chimeric antigen receptor optimizes tonic signaling and CAR-T cell fitness.CELL RESEARCH;.浏览/下载:931/280; 被引[WOS]:77; IF:28.1/36.4评论推荐收藏
 [5] Haopeng Wang,Wentao Li,Shizhen Qiu,et al. Ubiquitination-lacking Chimeric Antigen Receptor And Use Thereof. 2022-09-08.浏览/下载:384/0评论推荐收藏
 [6] 王ハオ鵬,Li WT,Qiu SZ,et al. Ubiquitination-deficient Chimeric Antigen Receptors And Their Use. 2022-07-04.浏览/下载:253/0评论推荐收藏
 [7] Li, Wentao,Yang, Han,Li, Li,&Wang, Haopeng.(2020).CAR trafficking does matter: prospects of 'Chimeric antigen receptor designed to prevent ubiquitination and downregulation showed durable antitumor efficacy'.JOURNAL OF MOLECULAR CELL BIOLOGY,12(9),745-746.浏览/下载:424/0; 被引[WOS]:2; IF:5.3/6.1评论推荐收藏
 [8] Li, Wentao.,Qiu, Shizhen.,Chen, Jian.,Jiang, Shutan.,Chen, Wendong.,...&Wang, Haopeng.(2020).Chimeric Antigen Receptor Designed to Prevent Ubiquitination and Downregulation Showed Durable Antitumor Efficacy.IMMUNITY,53(2),456-+.浏览/下载:603/28; 被引[WOS]:110; IF:25.5/33.2评论推荐收藏
 [9] WANG Haopeng, LI Wentao, QIU Shizhen,et al. Ubiquitination-deficiency Chimeric Antigen Receptor And Uses Thereof. 2019-10-31.浏览/下载:243/1评论推荐收藏
 [10] 王皞鹏, 李文涛, 邱士真,等. 一种泛素化缺失的嵌合抗原受体及其用途. 2019-04-16.浏览/下载:286/0评论推荐收藏